organization · Reporting owner
BCTG Holdings, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tango Therapeutics, Inc.TNGX · Entity 1497 | 10% owner | August 10, 2021 | August 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tango Therapeutics, Inc.
Report date August 10, 2021 · Filed August 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,988,450 |
Reported balance
Holding disclosure · report date 2021-08-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 6,988,450 F1: These securities are owned directly by BCTG Holdings, LLC ("BCTG Holdings"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, (v) MVA Investors, LLC and (vi) Aaron I. Davis (collectively, the "Boxer Group"). Each member of the Boxer Group other than BCTG Holdings disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by BCTG Holdings, LLC ("BCTG Holdings"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, (v) MVA Investors, LLC and (vi) Aaron I. Davis (collectively, the "Boxer Group"). Each member of the Boxer Group other than BCTG Holdings disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2020 Filed Nov 25, 2020 02:30 UTC | Tango Therapeutics, Inc. BCTG · Entity 1497 | SaleCommon Stock | 2,500 | $0.01 | $15.00 |
DisclosureSEC source: 0001213900-20-039174 · ownership.xml · nonDerivative · entry 2 BCTG Holdings, LLC · CIK 0001823427 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,488,450 F1 · acquired: On November 20, 2020, BCTG Holdings, LLC transferred 2,500 founder shares to an advisor at the original purchase price of the shares. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 02:30 UTC | Tango Therapeutics, Inc. BCTG · Entity 1497 | SaleCommon Stock | 2,500 | $0.01 | $15.00 |
DisclosureSEC source: 0001213900-20-039174 · ownership.xml · nonDerivative · entry 1 BCTG Holdings, LLC · CIK 0001823427 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,490,950 F1 · acquired: On November 20, 2020, BCTG Holdings, LLC transferred 2,500 founder shares to an advisor at the original purchase price of the shares. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:33 UTC | Tango Therapeutics, Inc. BCTG · Entity 1497 | PurchaseCommon Stock | 533,500 | $10.00 | $5,335,000.00 |
DisclosureSEC source: 0001213900-20-026144 · ownership.xml · nonDerivative · entry 1 BCTG Holdings, LLC · CIK 0001823427 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,493,450 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.